Recombinant γ-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients
✍ Scribed by Juan Antonio Quiroga; Inmaculada Castillo; Juan Carlos Porres; Santos Casado; Federico Sáez; María Gracia Martínez; Mariano Gómez; Luis Inglada; Luis Sánchez-Sicilia; Adela Mora; Fernando Galiana; Guillermina Barril; Dr. Vicente Carreño
- Book ID
- 102238101
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 316 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Pharmacokinetics, tolerance and biological effects of human recombinant y-interferon were studied in 12 patients with chronic active hepatitis B. Serum concentrations of y-interferon were measured by radioimmunoassay in four patients after a subcutaneous injection of 10 million U (0.6 mg); the peak
## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for